ALDER BIOPHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 31 Oct 2022)
What this means for you
This application is over — abandoned 31 Oct 2022. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88375604
- Mark type
- Design + words
- Filed
- 08 Apr 2019
- Published for opposition
- 30 Jul 2019
- Abandoned
- 31 Oct 2022
- Attorney of record
- Maren C. Perry
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations used for the prevention, management and treatment of headaches, migraines, pain, immune and inflammatory disorders and diseases, and neurological disorders and conditions
Owner
- LUNDBECK SEATTLE BIOPHARMACEUTICALS, INC., BOTHELL, WA, US
- Alder BioPharmaceuticals, Inc., Bothell, WA, US
- Alder BioPharmaceuticals, Inc., Bothell, WA, US
Prior registrations
Prosecution history
- 31 Oct 2022 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 31 Oct 2022 — ABANDONMENT - NO USE STATEMENT FILED
- 18 Feb 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Feb 2022 — SOU EXTENSION 5 GRANTED
- 10 Feb 2022 — SOU EXTENSION 5 FILED
- 17 Feb 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 10 Feb 2022 — SOU TEAS EXTENSION RECEIVED
- 26 Aug 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Aug 2021 — SOU EXTENSION 4 GRANTED
- 24 Aug 2021 — SOU EXTENSION 4 FILED
- 24 Aug 2021 — SOU TEAS EXTENSION RECEIVED
- 19 Mar 2021 — ASSIGNED TO EXAMINER
- 27 Feb 2021 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Feb 2021 — SOU EXTENSION 3 GRANTED
- 25 Feb 2021 — SOU EXTENSION 3 FILED